3 months ago
12
CHASKA, Minn., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore”), a fully integrated contract development and manufacturing organization ("CDMO”), today announced that the company will participate in multiple upcoming investor conferences and industry events. Details regarding Lifecore's participation are as follows:
- TD Cowen 45th Annual Health Care Conference
Details: Paul Josephs, chief executive officer, will deliver a corporate presentation and Lifecore management will participate in investor meetings
Presentation Date/Time: Tuesday, March 4, 2025, 9:50 - 10:20 a.m. ET
Conference Dates: March 3-5, 2025
Get the latest news
delivered to your inboxSign up for The Manila Times newsletters
By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy.
Location: Boston, MA
- KeyBanc Capital Markets Healthcare Forum
Details: Mr. Josephs will participate in a fireside chat and Lifecore management will participate in investor meetings
Fireside Chat Date/Time: Wednesday, March 19, 2025, 3:00 - 3:35 p.m. ET
Conference Dates: March 18-19, 2025
Location: Virtual
- DCAT Week 2025
Details: Lifecore team will participate in meetings with current and prospective customers and attend networking events
Conference Dates: March 17-20, 2025
Location: New York, NY
A live webcast of the TD Cowen presentation may be accessed via a link on Lifecore's investor website on the Investor Events & Presentations page at: https://ir.lifecore.com/events-presentations. Additionally, a replay of the webcast will be available on the Lifecore website following the conference.
About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore's website at www.lifecore.com.
CONTACT: Lifecore Biomedical, Inc. Contact Information:
Vida Strategic Partners
Stephanie Diaz (Investors)
415-675-7401
Tim Brons (Media)
415-675-7402
Ryan D. Lake (CFO)
Lifecore Biomedical
952-368-6244
